Aim: Vasopressin exerts robust influences on social communication and behavior in humans. Apelin is a relatively novel neuropeptide that could counteract vasopressin's actions and has been shown to be closely related with a broad range of physiological functions. Abnormalities in vasopressin and apelin have been detected in a variety of psychiatric disorders, but their relation to attention-deficit hyperactivity disorder (ADHD) is unknown. In the present study, we explored the plasma levels of vasopressin and apelin-13 in children with ADHD.
A TTENTION-DEFICIT HYPERACTIVITY DISOR-DER (ADHD) is a childhood-onset neurodevelopmental condition characterized by inattention, hyperactivity, and/or impulsivity that can persist into adulthood with deleterious effects on social, academic, and behavioral outcomes. 1 The etiology of ADHD involves complex interactions of neuroanatomical and neurochemical systems, but the precise neurobiological mechanisms underlying the disorder are currently unclear. Understanding the etiopathogenesis of ADHD would aid in both its diagnosis and in the development of new treatments for this complex disorder.
The vasopressinergic system in the brain participates in the modulation of social behaviors, including social communication, parental care, parent-offspring bonding, pair-bonding, and sexual behavior. 2 Because social deficiencies are core symptoms of autism spectrum disorders (ASD), in recent years, a growing number of studies have investigated the potential relation between the vasopressinergic system and ASD. [3] [4] [5] These studies have yielded conflicting results regarding the alteration of blood vasopressin concentrations in ASD subjects. Social communication and behavior deficits are also shown in patients with ADHD, but only a preliminary study has so far investigated the association between the vasopressinergic system and ADHD. 6 In that study, van West et al. reported that a genetic variation in the vasopressin receptor 1b gene may play a role in the vulnerability of ADHD. 6 There is also some indirect evidence from studies that investigated the role of oxytocin for etiopathogenesis of ADHD. 7, 8 Similar to vasopressinergic systems, the oxytocinergic system modulates social interactions in humans and recent studies suggest that insufficient oxytocin activity may play a role in the etiopathogenesis of ADHD. 7, 8 Apelin is a relatively newly discovered neuropeptide that plays a critical role in the regulation of the vasopressinergic system. [9] [10] [11] Similar to vasopressin, apelin is expressed by magnocellular neurons of the paraventricular and supraoptic nuclei of the hypothalamo-neurohypophysial system. 9, 10 Apelin has been classified according to the number of amino acids and its highest activity subtype is apelin-13. 12 Apelin is expressed throughout the body and plays a role in a broad range of physiological functions, such as cardiovascular homoeostasis, lipid and glucose metabolism, and immunity. [13] [14] [15] Apelin and apelin receptors are also widely distributed in the central nervous system, which suggests it plays an important role in the neuronal signaling pathway. 10, 11 Only a few studies have investigated the role of apelin in neuropsychiatric disorders; however, these studies have pointed out the potential role of this neuropeptide. Boso et al. found significantly reduced plasma apelin levels with elevated concentrations of vasopressin in patients with ASD. 4 An experimental study showed that centrally administered apelin-13 elicited depression-like behavior in mice. 16 Alternatively, a recent study reported the anxiolytic action of apelin-13 in male mice. 17 Interestingly, two other studies reported a marked activation of locomotion with apelin-13 in animals. 18, 19 Therefore, as well as vasopressin, investigating the association of apelin and ADHD may be important for elucidating the etiopathogenesis of ADHD.
The aim of this study was to investigate whether serum levels of vasopressin and apelin-13 in children with ADHD differ from those of sex-and agematched healthy controls. The present study also examined the relation between serum vasopressin and apelin-13 levels and clinical symptoms in ADHD children. We hypothesized that lower plasma vasopressin levels and higher plasma apelin-13 levels are related to ADHD.
METHODS

Subjects
Children with a diagnosis of the ADHD combined subtype were enrolled in this study. Exclusion criteria included the presence of a major physical/neurological illness (e.g., cardiovascular disorders, epilepsy), head trauma, history of enuresis, comorbid psychiatric disorders other than oppositional defiant disorder, conduct disorder and specific phobia, substance abuse, and an IQ score below 70 according to the Turkish version of the Wechsler Intelligence Scale for Children-Revised. 20, 21 Patients who had a history of taking psychiatric medications were also excluded. The control group consisted of healthy volunteer children who were age-and sex-matched with the ADHD subjects. This study was approved by the Necmettin Erbakan University Ethics Committee and all of the study procedures were in accordance with the Declaration of Helsinki and local laws and regulations. The parents who agreed to have their children take part were provided with a patient information sheet that outlined the research protocol; the parents also provided their written informed consent. Oral assent was also procured from all of the children.
Psychological assessment
All children were interviewed by an experienced child and adolescent psychiatrist using the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children -Present and Lifetime Version (K-SADS-PL). 22, 23 Diagnoses of the ADHD combined presentation were made according to DSM-5 criteria. Parents completed Conners' Parent Rating Scale-Revised Short (CPRS-RS) and teachers completed Conners' Teacher Rating Scale-Revised Short (CTRS-RS). [24] [25] [26] [27] Both the CPRS-RS and CTRS-RS include Inattention/Cognitive Problems, Hyperactivity, and Oppositional Behavior subscales, and both allow for screening of ADHD symptoms.
Blood samples
Venous blood samples were drawn from an antecubital vein between 08.00 and 10.00 hours after an overnight fast. Blood samples were centrifuged and the plasma was frozen at −80 C until assayed.
Plasma levels of vasopressin and apelin-13 were measured using commercial enzyme-linked immunosorbent assay (ELISA) kits following the manufacturers' protocols (for vasopressin, Cusabio Biotech Co., Wuhan, China; for apelin-13, Elabscience Biotech Co., Wuhan, China).
Statistical analysis
Statistical analyses were performed with SPSS 21.0 (SPSS Inc., Chicago, IL, USA). When the normality of the distribution of variables was acceptable, the Student's t-test was used. In other cases, the MannWhitney U-test was used to analyze differences between groups. The Pearson or Spearman correlation coefficient was calculated to examine the relation between the plasma vasopressin and apelin-13 levels and psychological test scores. A value of P < 0.05 (two-tailed) was considered to indicate significance.
RESULTS
Three of the parents refused to participate in the study and 14 children were excluded based on the exclusion and inclusion criteria. The final study population consisted of 34 children (24 boys/10 girls) with ADHD and 36 healthy controls (23 boys/13 girls) (χ 2 = 0.36, P = 0.551). The mean age did not differ significantly between the patient (10.5 AE 2.1 years) and control (10.3 AE 2.0 years) groups (range: 7-15 years; z = 0.34; P = 0.747). Twenty subjects were also diagnosed as having an oppositional defiant disorder, five subjects were diagnosed with a conduct disorder, and nine with a specific phobia according to DSM-5 criteria. All of the mean CPRS-RS and CTRS-RS scores were significantly higher for patients than for controls. The demographic and clinical features of the participants for the whole group and for both sexes are summarized in Table 1 .
Plasma vasopressin levels of the study and control groups did not show significant differences for either sex or for the whole group (Table 1) . Plasma apelin-13 levels were significantly higher in the ADHD group (1384 AE 1403 ng/mL) than in controls (666 AE 768 ng/mL) in boys (z = 2.57, P = 0.01, r = 0.31) (Fig. 1 ), but they were not significantly different in girls or between whole groups (Table 1) . Correlations between plasma vasopressin and apelin-13 levels and the CPRS-RS and CTRS-RS scores were also evaluated in the ADHD group for both sexes and in the total subject cohort. No association was found for these hormone levels and psychological test scores. Sex differences in plasma levels of vasopressin and apelin-13 and the change of these hormones by age in healthy controls were also assessed. Plasma apelin-13 levels were significantly lower in boys (666.1 AE 767.7 ng/mL) than in girls (1602.5 AE 1905.8 ng/mL) (z = −2.19, P = 0.028, r = 0.37). However, plasma vasopressin levels did not show a significant difference between the male (14.0 AE 12.9 ng/mL) and female (7.9 AE 6.2 ng/mL) (z = −1.42, P = 0.157, r = 0.24) groups. Correlations between plasma levels of apelin-13 and vasopressin and age of controls were not significant in boys (r = −0.23, P = 0.294 and r = 0.126, P = 0.565, respectively), girls (r = 0.33, P = 0.268 and r = 0.28, P = 0.349, respectively) or the whole group (r = −0.12, P = 0.473 and r = 0.24, P = 0.159, respectively).
DISCUSSION
To the best of our knowledge, this is the first study investigating plasma vasopressin and apelin-13 levels in children with ADHD. The results obtained indicated no significant alterations of plasma vasopressin and apelin-13 levels in children with ADHD in the whole group. However, while plasma levels of these neuropeptides were stratified for sex, we found that plasma apelin-13 levels in male subjects with ADHD were significantly higher than those of healthy controls. Thus, the results of this study suggest a possible sex-specific association of apelin-13 with ADHD.
Though only one study has assessed the relation between the vasopressin system and ADHD, 6 some data may be considered as evidence for the potential effect of this system in the etiopathogenesis of ADHD. For instance, ADHD and ASD are highly comorbid and both disorders share similar neurocognitive deficits, including poor theory of mind. 28 Several studies have pointed out that there are altered blood vasopressin levels in ASD. 4, 29 Furthermore, a recent study reported a positive correlation between plasma vasopressin levels and theory of mind ability in ASD subjects and posited that blood vasopressin levels are a robust biomarker of theory of mind ability in children with ASD. 3 Because ADHD is related strongly with aggression, studies that showed the association between aggression and the vasopressin system may also indicate the possible role of vasopressin in ADHD. 30, 31 On the other hand, both oxytocin and vasopressin are regarded as social hormones and are closely related neuropeptides; recent studies that reported relations between ADHD and the oxytocinergic system have also suggested the link between the vasopressinergic system and ADHD. 7, 8 The present study found no significant difference between the ADHD and control groups for plasma vasopressin levels and could not provide any direct evidence concerning the possible role of vasopressin in ADHD. However, the link between blood vasopressin concentration and ADHD must be evaluated through additional studies.
To our knowledge, no previous studies had investigated the relations between apelin and ADHD. Our findings showed higher plasma apelin-13 levels in boys with ADHD than healthy boys. Apelin has been considered as a natural inhibitor of the effect of vasopressin; therefore, it could play a role in the pathophysiology of ADHD via its inhibitory impacts on the vasopressinergic system. Moreover, given the increased effect of apelin-13 on locomotor activity in animals, 18, 19 apelin-13 may also cause a vulnerability for ADHD with its direct effects on apelin receptors. ADHD is a disorder that exhibits wellknown sex differences in prevalence, clinical course, and etiopathogenesis. Many genes have sexually dimorphic effects in ADHD and sex differences in this disorder are suggested to be the result of hormonal influences on gene expression. 32, 33 Therefore, the sex-specific association of apelin-13 with ADHD may be associated with the effects of apelin-13 on the expression of some sexually dimorphic genes. In line with this point of view, the vasopressinergic system has been previously suggested to be related with male-typical social behaviors, including aggression and territoriality. 34 Additionally, it has been reported that the impaired effects of central administration of selective vasopressin 1a receptor antagonists on social functioning in rodents are more prominent in males. 35 Future research that evaluates the potential role of blood apelin concentration and apelin receptors in ADHD is needed to confirm and expand the present findings.
Because our findings posit a sex-specific association of apelin-13 with ADHD, we also investigated the potential differences between sexes in respect to plasma hormone levels. Thus, we compared plasma apelin-13 and vasopressin levels of male and female healthy controls. Analysis showed lower apelin-13 levels in boys than in girls. This result suggests that circulating apelin-13 levels may show an alteration according to sexes in healthy individuals. Accordingly, apelin-13 may have different influences in males and females. We also assessed the change of plasma hormone levels by age in healthy controls and no correlation was detected.
The exclusion of comorbid systemic and psychiatric disorders, including enuresis, is a strong point of this study. However, this study also has several limitations. The main limitation of this study was its small sample size. Another limitation was that, due to a limited age range and a low number of girls, we cannot expand our results to all ADHD patients. Additionally, our sample consisted of only subjects with the ADHD combined presentation; therefore, children with the ADHD predominantly inattentive presentation and those with the predominantly hyperactive/ impulsive presentation could not be evaluated.
This study provides preliminary evidence regarding the role of apelin-13 in the etiopathogenesis of ADHD in males. While the neurobiological mechanisms underlying ADHD are not well known, understanding the potential role of apelin-13 in ADHD would aid in both the diagnosis and development of new treatments of this complex disorder. Our study will be followed by future studies with larger samples to better identify the possible role of apelin-13 in ADHD.
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